# Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation

> **NCT01103310** · PHASE1 · COMPLETED · sponsor: **Life Molecular Imaging SA** · enrollment: 46 (actual)

## Conditions studied

- Diagnostic Imaging
- Neoplasms

## Interventions

- **DRUG:** BAY94-9392

## Key facts

- **NCT ID:** NCT01103310
- **Lead sponsor:** Life Molecular Imaging SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103310, "Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01103310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*